Merit Medical Systems, Inc. is a manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. The company operates through two segments: cardiovascular and endoscopy. Its cardiovascular segment includes products for peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturing, with key offerings in renal therapies, angiography, drainage, delivery systems, embolotherapy, and oncology. The endoscopy segment provides devices for interventional pulmonology, nephrology, and gastroenterology. Merit serves hospitals and healthcare systems worldwide across North America, Europe, Asia, Oceania, and South America. Founded in 1987, the company designs, develops, and manufactures products through its own operations and contract manufacturers, offering custom procedural solutions such as kits and trays.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Devices Homepage merit.com
Sector Healthcare IR page merit.com/investors
Tags
vascular access, hemodialysis, peripheral intervention, oncology, drainage systems, embolotherapy, endoscopy, interventional radiology, cardiology, disposable medical devices, Prelude Introducer Sheaths, Merit Wrapsody Cell-Impermeable Endoprosthesis, HeRO Graft, CentrosFLO Long-Term Hemodialysis Catheter, ProGuide Chronic Dialysis Catheter, BioFlo DuraMax Catheter, Surfacer Inside-Out Access Catheter System, Merit SplashWire hydrophilic Steerable Guide Wires, Performa Diagnostic Catheters, Impress Diagnostic Catheters, Aspira Pleural Effusion Drainage, Aspira Peritoneal Drainage Systems, ReSolve Drainage Catheters, ReSolve ConvertX Stent System, ReSolve Mini Locking Drainage Catheter, One-Step Drainage Catheters, Valved One-Step Drainage Catheters, Revolution Catheter Securement Device, StayFIX Fixation Device, SwiftNINJA Steerable Microcatheter, Merit Maestro Microcatheters, Merit Pursue Microcatheters, True Form Reshapable Guide Wire, Embosphere Microspheres, HepaSphere Microspheres, Siege Vascular Plug, ClariVein Specialty Infusion Catheter, Dynamis AV PTA Dilatation Catheter, Q50X Stent Graft Balloon Catheters, Q50 Stent Graft Balloon Catheters, Fountain Infusion System, Mistique Infusion Catheters, EN Snare Endovascular Snare Systems, One Snare Endovascular Snare Systems, SCOUT Radar Localization System, OneMark Detection Imaging System
Press page merit.com/investors/press-releases

Metrics

Valuation  
Market cap $ 5.171B
Market cap (USD) $ 5.171B
P/E 32.33
PEG 1.62
P/BV 2.96
P/S 3.21
P/OCF 18.89
P/FCF 25.40
Dividend yield —
Turnover / mcap —
Returns  
ROE 8.7%
ROI 5.5%
ROIC 6.0%
Profit margin 8.5%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 19.9%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 42.3%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 24
Quality score 11.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 1.516B 1.357B 1.257B 1.151B 1.075B 963.875M 994.852M 882.753M 727.852M 603.838M 542.149M 509.689M 449.049M 394.288M 359.449M 296.755M 257.462M 227.143M 207.768M 190.674M 166.585M 151.398M 135.954M 116.227M 104.036M 91.448M
Net profit 128.489M 120.357M 94.411M 74.516M 48.454M -9.843M 5.451M 42.017M 27.523M 20.121M 23.802M 22.974M 16.57M 19.71M 23.044M 12.46M 22.53M 20.727M 15.588M 12.301M 15.778M 17.932M 17.295M 11.31M 6.736M 826.557K
Free cash flow 215.655M 185.659M 110.861M 69.262M 119.292M 119.282M -360K 23.209M 24.104M 20.762M 18.499M 19.144M -8.132M -17.705M -25.18M 11.112M — — — — — — — — — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 88.14 96.72 75.96 70.62 62.3 55.51 31.22 55.81 43.2 26.5 18.59 17.33 15.74 13.9 13.44 15.82 17.79 17.74 12.04 16.13 — 22.5 22.5 19.96 14.85 —
Price performance 12m -0.09 0.27 0.08 0.13 0.12 0.78 -0.44 0.29 0.63 0.43 0.07 0.1 0.13 0.03 -0.15 -0.11 0 0.47 -0.25 — — 0 0.13 0.34 — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 80.5M 106M 137M 155M 147M 152M 165M 178M 190M 204M
↳ YoY growth +14.6% +31.1% +30.0% +13.3% -5.6% +3.9% +8.1% +8.0% +6.9% +7.1%
↳ 5y CAGR +14.7% +14.6% +17.9% +16.4% +15.8% +13.6% +9.3% +5.3% +4.1% +6.8%
Borrowings, current (USD) 10M 26.4M 29M 7.5M 7.5M 8.44M 11.3M — — —
Borrowings, non-current (USD) 314M 259M 373M 432M 344M 234M 187M 823M 730M 734M
Lease liabilities (USD) — — — 84.3M 83.8M 72.2M 70.7M 68.3M 65.1M 87.5M
Cash and deposits (USD) 19.2M 32.3M 67.4M 44.3M 56.9M 67.8M 58.4M 587M 377M 446M
Intangible assets (USD) — — 79.6M — — — — — — —
Right-of-use assets (USD) — — — 80.2M 78.2M 65.9M 65.3M 63M 65.5M 87.6M
Net debt (borrowings + leases - cash) (USD) 305M 253M 335M 479M 378M 247M 210M 304M 418M 375M
Cash flow detail
Operating cash flow (USD) 53.6M 62.7M 86.5M 77.8M 165M 147M 114M 145M 221M 297M
Purchases of property, plant and equipment (USD) -32.8M -38.6M -63.3M -78.2M -46M -27.9M -45M -34.3M -35.1M -81.7M
Purchases of intangible assets (USD) -2.22M -2.58M -3.01M -3.32M -3.29M -2.83M -3.18M -2.41M -2.9M -3.12M
Change in receivables (cash effect) (USD) -6.82M -12.8M -27.5M -17.9M 10.4M -8.62M -15.1M -11.9M -13.7M -7.34M
Change in inventories (cash effect) (USD) -3.66M -17.8M -28.2M -27M 29.4M -25.2M -47.9M -32.1M -2.29M -21.6M
Interest paid (cash effect) (USD) -8.87M -7.71M -10.3M -12.4M -10.1M -5.26M -6.26M -14.1M -23.2M -21M
Income taxes paid (cash effect) (USD) -2.32M -6.05M -8.69M -12.1M -8.92M -8.83M -17.1M -31.5M -45M -31.4M
Share-based compensation (USD) 2.51M 4.08M 6.12M 9.38M 14.3M 16.1M 18M 21.3M 28.5M 43.5M
Operating cash flow before change in receivables (USD) 60.4M 75.6M 114M 95.7M 155M 156M 129M 157M 234M 305M
Free cash flow (OCF - PPE - intangibles) (USD) 18.5M 21.5M 20.2M -3.68M 116M 116M 66.1M 108M 183M 213M
Income detail
Research and development expense (USD) 45.2M 51.4M 59.5M 65.6M 57.5M 71.2M 75.5M 82.7M 87.5M 97.4M
↳ 5y CAGR +15.6% +13.1% +11.9% +12.4% +7.1% +9.5% +8.0% +6.8% +5.9% +11.1%
Total comprehensive income (USD) 23.7M 30.9M 38.5M 1.44M -10M 45.9M 71M 94.6M 112M 144M
Reported Mar 1, 2017 Mar 1, 2018 May 3, 2019 Mar 2, 2020 Mar 1, 2021 Mar 1, 2022 Feb 24, 2023 Feb 28, 2024 Feb 25, 2025 Feb 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

PR/Media Inquiries: Sarah Comstock Bull 5 Bear 0 Results

Merit Medical

Investor Inquiries:

Mike Piccinino, CFA, IRC

ICR Healthcare

+1-801-432-2864

+1-443-213-0509

[email protected]

[email protected]

FOR IMMEDIATE RELEASE

MERIT MEDICAL REPORTS THIRD QUARTER 2026 RESULTS: DELIVERS 9% ORGANIC CONSTANT CURRENCY REVENUE GROWTH AND RAISES FULL-YEAR 2026 GUIDANCE

Financial Highlights†

● Reported revenue of $416.2 million, up 8.4%

● Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectively

● GAAP operating margin of 14.1%, compared to 11.1% in prior year period

● Non-GAAP operating margin* of 21.3%, compared to 19.7% in prior year period

● GAAP EPS $0.70, up 51%

● Non-GAAP EPS* $1.12, up 22%

● Cash flow from operations of $175.2 million year-to-date

● Free cash flow* generation of $129.5 million year-to-date

† Comparisons above are calculated for the current quarter compared with the third quarter of 2025, unless otherwise specified. Amounts stated in this release are rounded, while percentages are calculated from the underlying amounts.

October 06, 2026 16:30 ET | Source: Merit Medical Systems, Inc. Follow Merit Medical Systems, Inc.

Share

SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

To access the conference call, please pre-register using the followinglink**.**Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling approximately 900 individuals. Merit employs approximately 7,500 people worldwide.

| Contacts: | |

| PR/Media Inquiries: Sarah Comstock Merit Medical | Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare |

| +1-801-432-2864 | +1-443-213-0509 |

| [email protected] | [email protected] |

GlobeNewswire

Company ProfileMerit Medical Systems, Inc.Industry: Health Care Equipment & ServicesWebsite:

https://merit.com

Press Release Actions

Recommended Reading

Merit Medical to Participate in Upcoming Investors Conferences in September

SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to...

Read More

Merit Medical to Participate in Upcoming Investors Conferences in September

Merit Medical Announces Global Operations Leadership Transition

SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed...

Read More

Merit Medical Announces Global Operations Leadership Transition

Explore

October 29, 2026 08:07 ET

BendPak Delivers OctaFlex™: World’s First Eight-Arm Lift Saves Hours per Job

TUK Group to Acquire Bayview Avenue Site Off the Bridle Path for 30-Unit Rental Development, Expanding Toronto Footprint

October 29, 2026 08:00 ET

TUK Group to Acquire Bayview Avenue Site Off the Bridle Path for 30-Unit Rental Development, Expanding Toronto Footprint

MilliporeSigma Announces the Opening of €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea

October 29, 2026 08:00 ET

MilliporeSigma Announces the Opening of €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea

Merck Opens €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea

October 29, 2026 08:00 ET

Merck Opens €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea

H&R Block’s Fund Her Future names four winners, survey reveals entrepreneurs value human support for their finances

October 29, 2026 08:00 ET

H&R Block’s Fund Her Future names four winners, survey reveals entrepreneurs value human support for their finances

❮

❯

About Us

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.

Global News

Newswire Distribution Network & Management

© 2026 Digital Media Innovations, LLC. All rights reserved.

GlobeNewswire LinkedinNotified Twitter

;

FrançaisDeutsch

September 04, 2026 09:25 ET | Source: Merit Medical Systems, Inc. Follow Merit Medical Systems, Inc.

Share

SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences:

**The Wells Fargo 2026 Healthcare Conference,**which is being held in Boston, MA from September 8-10, 2026.

  • Management is scheduled to participate in a fireside chat on Thursday, September 10th at 8:45 a.m. Eastern Time.

**The Baird 2026 Global Healthcare Conference,**which is being held in New York, NY on September 15, 2026.

  • Management is scheduled to present on Tuesday, September 15th at 8:30 a.m. Eastern Time.

**The 19th Annual Barrington Research Virtual Fall Investment Conference,**which is being held virtually on September 22, 2026.

  • Management is scheduled to participate in 1x1 meetings only, with no formal presentation session.

**The Sidoti Small Cap Conference,**which is being held virtually from September 23-24, 2026.

  • Management is scheduled to participate in 1x1 meetings only on Wednesday, September 23rd, with no formal presentation session.

Live audio webcasts of the fireside chats will be accessible under the “Events” section of Merit’s investor relations website at Investor Events and Presentations - Merit Medical. Replays of the fireside chats will be available on this same website for approximately 90 days.

ABOUT MERIT MEDICAL

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,500 people worldwide.

Prompts

Merit Medical Systems, Inc. (ticker MMSI), listed in United States.

Company History

Date Change Detail
Aug 13, 2010 Acquired Acquired Biosphere Medical Inc (CIK 919015). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Merit Medical Systems, Inc.

ETF Weight in ETF Shares Market value As of
AFSC 3.15% 3,718 $ 316.067K Jul 31, 2026
NBSM 1.07% 13,569 $ 1.23M Aug 31, 2026
LITL 0.55% 373 $ 31.515K Nov 17, 2026
WCEO 0.55% 641 $ 54.491K Jul 31, 2026
FSEG 0.37% 304 $ 21.079K Jun 30, 2026
AVSC 0.22% 80,679 $ 6.967M Nov 16, 2026
RESM 0.19% 99 $ 6,864.66 Jun 30, 2026
PSC 0.18% 61,295 $ 4.25M Jun 30, 2026
SQLV 0.16% 679 $ 47.082K Jun 30, 2026
DFAS 0.12% 453,366 $ 39.302M Nov 12, 2026
DFAT 0.11% 387,670 $ 33.607M Nov 12, 2026
JMEE 0.10% 32,440 $ 2.741M Nov 17, 2026
RUSC 0.09% 1,052 $ 72.946K Jun 30, 2026
FSML 0.07% 1,334 $ 92.5K Jun 30, 2026
RILA 0.06% 274 $ 23.293K Jul 31, 2026
SMDX 0.05% 737 $ 63.64K Nov 17, 2026
DFUV 0.03% 47,481 $ 4.116M Nov 12, 2026
MSSM 0.02% 1,707 $ 154.757K Aug 31, 2026
DFSU 0.02% 5,171 $ 448.274K Nov 12, 2026
DFAC 0.02% 183,417 $ 15.9M Nov 12, 2026
FESM 0.02% 14,145 $ 980.814K Jun 30, 2026
DFSV 0.01% 45,019 $ 3.903M Nov 12, 2026
DCOR 0.01% 66,095 $ 5.73M Nov 12, 2026
DXUV 0.01% 8,810 $ 763.739K Nov 12, 2026
AVUS 0.01% 13,995 $ 1.208M Nov 16, 2026
AVSU 0.01% 362 $ 31.259K Nov 16, 2026
DFAU 0.01% 12,195 $ 1.057M Nov 12, 2026
DFUS 0.01% 17,701 $ 1.534M Nov 12, 2026
EBI 0.00% 112 $ 10.154K Aug 31, 2026
THRO 0.00% 22 $ 1,899.70 Nov 16, 2026